Canada vs Germany: Cause of death, by non-communicable diseases, ages 15-59, male
Canada
76.8%
in 2021
Germany
78.2%
in 2021
Canada rank
5th
Germany rank
3rd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Canada
- Germany
How they compare
Germany currently reports 78.2% against 76.8% in Canada, a difference of 1.4%.
Across all 6 years both countries report, Germany has been ahead every year.
Canada ranks 5th and Germany ranks 3rd of 185 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.5% | 78.9% | 9.4% | Germany |
| 2010s | 73.2% | 82.3% | 9.1% | Germany |
| 2020s | 77.2% | 80.0% | 2.7% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Canada or Germany?
- Germany, at 78.2% against 76.8% in Canada as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Canada and Germany?
- 1.4%, with Germany ahead.
- How many years of comparable data are there for Canada and Germany?
- 6 years are reported by both, from 2000 to 2021.
- How do Canada and Germany rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Canada ranks 5th and Germany ranks 3rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.